Companies » Company Overview » Astrazeneca Pharma India Ltd.
 
 

Astrazeneca Pharma India Ltd.

  • BSE: 506820
  • Sector: Health care
  • NSE: ASTRAZEN
  • ISIN Code: INE203A01020
  • BSE

    LIVE

    15:49 | 22 May

  • 863.10
  • 2.55
    (0.30%)
  • Open
    875.00
  • HIGH
    875.00
  • LOW
    862.40
  • NSE

    LIVE

    15:41 | 22 May

  • 863.60
  • 3.40
    (0.40%)
  • Open
    860.00
  • HIGH
    877.00
  • LOW
    860.00
 
bse
15:49 PM,22nd May 2015
863.10
2.55 (0.30%)
Previous Close 860.55
Volume 387
52-Week high 1245.00
52-Week low 785.30
P/E -
Mkt Cap.(Rs cr) 2158
Bid Price 0.00
Bid Quantity 0.00
Offer Price 0.00
Offer Quantity 0.00
NSE
15:41 PM,22nd May 2015

863.60
3.40 (0.40%)
Bse
15:49 PM,22nd May 2015

863.10
2.55 (0.30%)
nse
15:41 PM,22nd May 2015
863.60
3.40 (0.40%)
Previous Close 860.20
Volume 1705
52-Week high 1243.80
52-Week low 781.00
P/E -
Mkt Cap.(Rs cr) 2158
Bid Price 863.60
Bid Quantity 96.00
Offer Price 0.00
Offer Quantity 0.00

Astrazeneca Pharma India Ltd. (ASTRAZEN) - Company Information

Astrazeneca Pharma India formerly known as Astra-IDL (AIL), a joint venture of Astra Zeneca, UK and Hinduja controlled IDL is a market leader in local anesthetics with xylocaine. The, UB's 100% subsidiary, UB Biotek, has tied up with the Company to market its newly-patented anti-obesity nutraceutical. The herbal product, Hydroxycitrisol, extracted from garcinia (kokum), is one of two UB technologies to recently get US patents. It is due to complete clinical tests at AIL and may hit the marke... [More]

Key Fundamentals
Market Cap (Rs cr) 2,158
EPS - TTM (Rs)

[*S]

-
P/E Ratio (x)

[*S]

-
Face Value (Rs) 2
Latest Dividend (%) 175.00
Latest Dividend Date 09 Jul 2012
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*S]

68.64
P/B Ratio (x)

[*S]

12.57
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
862.40
875.00
Week Low/High
856.80
905.00
Month Low/High
852.35
929.00
YEAR Low/High
785.30
1245.00
All TIME Low/High
3.75
2649.00
Peer Group
Company Last Change(%)
Jubilant Life 171.00 -0.06
Marksans Pharma 58.45 -1.60
Shasun Pharma. 367.25 0.27
Astrazeneca Phar 863.10 0.30
Sequent Scien. 624.00 -0.32
Novartis India 606.10 0.02
Unichem Labs. 198.40 -0.23
Returns
Period Astrazeneca Phar Sensex NIFTY
1 Week -3.43% 2.32% 2.38%
1 Month -5.61% 0.24% 0.35%
3 Month 0.75% -4.36% -4.24%
6 Month 2.58% -1.33% -0.22%
1 Year -23.14% 14.70% 16.25%
3 Year -53.86% 74.45% 74.03%
Period Astrazeneca Phar Sensex NIFTY
1 Week -3.53% 2.32% 2.38%
1 Month -5.63% 0.24% 0.35%
3 Month 0.48% -4.36% -4.24%
6 Month 2.30% -1.33% -0.22%
1 Year -22.73% 14.70% 16.25%
3 Year -54.03% 74.45% 74.03%
Financial Results
Particulars (Rs cr) Dec 2014 Dec 2013 %Chg
Net Sales 108.2 118.96 -9.05
Other Income 1.1 1.58 -30.38
Total Income 109.31 120.53 -9.31
Total Expenses 118.34 115.99 2.03
Operating Profit -9.03 4.55 -298.46
Net Profit -13.41 1.52 -982.24
Equity Capital 5 5 -
SHAREHOLDING PATTERN
As on Mar 2015
Company information
Chairman : D E Udwadia
Director : K S Shah
Director : Ian Brimicombe
Director : Narayan K Seshadri
Director : Justin Ooi
Managing Director : Sanjay Murdeshwar
Company Secretary : Anantha Murthy N
Additional Director : Rebekah Martin
AUDITOR: BSR & Co LLP
IND NAME: Pharmaceuticals - Multinational
HOUSE NAME: MNC Associate
Registered office
Avishkar, Off Bellary Road Hebbal,
Bangalore,Karnataka-560024
Ph: 91-80-67748000
E-mail: comp.secy@astrazeneca.com
URL: http://www.astrazeneca/india.com

Quick Links

 
Quick Links for Astrazeneca Pharma India

Back to Top